INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

26,988 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
GS
Gummadi SuryaPresident - Americas
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$144K
1,728 sh
Feb 2, 2026
Page 527 of 675
← PrevNext →
Feb 4, 2026
traded Feb 2, 2026
+2d
SEC Form 4

Evidence

8
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$8,830
200 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

8
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$139K
5,262 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

6
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$8,388
720 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

6
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$108K
10.0K sh
Feb 4, 2026Feb 4, 2026
traded Feb 4, 2026
+0dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$159K
14.7K sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

5
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$6,477
2,540 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

5
SC
Saldanha CraigChief Product Officer
YELPYELP INC
Open-market sale · 10b5-1 plan
SELL$33K
1,200 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

3
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$30K
2,797 sh
Feb 4, 2026Feb 4, 2026
traded Feb 4, 2026
+0dSEC Form 4

Evidence

3
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,700 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

1
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$75K
381 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

1
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$1,398
556 sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC Form 4

Evidence

1
SN
Sieffert Kristen NPresident
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$17K
750 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

1
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
30.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$4,499
23 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$7,449
39 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$4,535
23 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$192
1 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC Form 4

Evidence

41
MJ
Malm JoshuaCFO
FEAM5E Advanced Materials, Inc.
Open-market purchase
BUY$7,500
3,750 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

37
RJ
Running Michael J.Regional President - AMER
PLXSPLEXUS CORP
Open-market sale
SELL$190K
926 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

33
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$117K
1,166 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

33
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$165K
1,662 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

30
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$49K
492 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

29
LE
Lee David EricVICE CHAIR, WINTRUST FINANCIAL
WTFCWINTRUST FINANCIAL CORP
Open-market sale
SELL$82K
558 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

26
DB
Dechairo BryanChief Operating Officer
WGSGeneDx Holdings Corp.
Open-market sale
SELL$8,999
93 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

25
ME
Moritz Robert Edward Jr.Director
NTRSNORTHERN TRUST CORP
Open-market purchase
BUY$37K
245 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

19
RL
Robinson Jill L.EVP, CFO & Treasurer
BATRKAtlanta Braves Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$800K
20.0K sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

10
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$84K
3,097 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

10
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$24K
50 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

9
OC
Ohlgart ChristianeChief Financial Officer
FTNTFortinet, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
507 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

6
JD
Jedrzejek DavidSVP and General Counsel
LEVILEVI STRAUSS & CO
Open-market sale · 10b5-1 plan
SELL$44K
2,248 sh
Feb 3, 2026Feb 3, 2026
traded Feb 3, 2026
+0dSEC Form 4

Evidence

4
BP
Badjate PramodPresident & GM, NFB
NTGRNETGEAR, INC.
Open-market sale · 10b5-1 plan
SELL$63K
3,000 sh
Feb 2, 2026Feb 3, 2026
traded Feb 2, 2026
+1dSEC Form 4

Evidence

1
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$38K
1,462 sh
Jan 30, 2026Feb 3, 2026
traded Jan 30, 2026
+4dSEC Form 4

Evidence

62
PJ
Pollino JenniferDirector
CRCrane Co
Open-market purchase
BUY$276K
1,500 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

62
KS
Kapoor SanjayDirector
CRCrane Co
Open-market purchase
BUY$500K
2,814 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

56
LD
Lynch Susan DDirector
CRCrane Co
Open-market purchase
BUY$18K
100 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

52
LD
Lynch Susan DDirector
CRCrane Co
Open-market purchase
BUY$8,878
50 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

47
MH
Mitchell Max HDirector, Chairman, President and CEO
CRCrane Co
Open-market purchase
BUY$184K
1,000 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

44
WK
Walsh KeithEVP and CFO
AIGAMERICAN INTERNATIONAL GROUP, INC.
Open-market purchase
BUY$406
6 sh
Dec 30, 2024Feb 2, 2026
traded Dec 30, 2024
+399dSEC Form 4

Evidence

41
BA
Bonnett Derek AChief Risk Officer
FCBCFIRST COMMUNITY BANKSHARES INC /VA/
Open-market purchase
BUY$17K
501 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence